BioSciences Group Newsroom

March 26, 2007  Westwood, MA

The BioSciences Group of Fujitsu Computer Systems Announces Name Change of CAChe Software Brand to Scigress Explorer, Launches Scigress Explorer 7.6 Version

Westwood, MA, March 26, 2007 – The BioSciences Group of Fujitsu Computer Systems Corporation today announced that it has renamed its flagship CAChe™ suite of desktop molecular modeling software to Scigress Explorer™, and also announced the availability of its latest edition of the high performance chemistry suite, Scigress Explorer™ 7.6.

March 26, 2007  Westwood, MA

The BioSciences Group of Fujitsu Computer Systems Announces U.S. Availability of Materials Explorer 4.0 Molecular Dynamics Simulator

Westwood, MA, March 26, 2007 – The BioSciences Group of Fujitsu Computer Systems Corporation today announced the U.S. launch of Materials Explorer® 4.0, a versatile software tool that provides researchers with advanced modeling capabilities to investigate the structure and properties of materials at the atomic and molecular level.

June 29, 2006  Westwood, MA

The Biosciences Group of Fujitsu Computer Systems Corporation Introduces Version 2.0 of CELLINJECTOR Automated Microinjection System

Westwood, MA, June 29, 2006 – Global leader in solutions for experimental scientists unveils first-ever microinjection system for adherent cells as well as suspended cells

May 2, 2006  Westwood, MA

The BioSciences Group of Fujitsu Announces New Technique for Increasing Efficiency in Transforming Difficult-to-Transfect Cells

Westwood, MA, May 2, 2006 – The BioSciences Group of Fujitsu Computer Systems today announced a new method that nearly doubles the efficiency of cell transformation in difficult-to-transfect cell types, based on the CELLINJECTOR™ automated microinjection technology.

December 13, 2005  San Francisco, CA, USA

The BioSciences Group of Fujitsu Announces CELLINJECTOR Evaluation Project with Whitehead Institute for High-Throughput Cell-Based Research

San Francisco, CA, December 13, 2005 – At the American Society for Cell Biology (ASCB) Annual Meeting today, the BioSciences Group of Fujitsu Computer Systems announced a new evaluation project with Whitehead Institute for Biomedical Research, focusing on high-throughput cell-based research.

August 10, 2005  Westwood, Massachusetts

The BioSciences Group of Fujitsu Introduces CELLINJECTOR™ Automated Microinjection System

Westwood, Massachusetts, August 10, 2005 – The BioSciences Group of Fujitsu Computer Systems today announced that it has developed an automated microinjection system called CELLINJECTOR, to enable very large-scale direct injection of agents through cell membranes for biochemical research.

July 11, 2005  Westwood, Massachusetts

The BioSciences Group of Fujitsu Unveils New in silico Technique for Enhanced ADME/Tox Predictions

Westwood, Massachusetts, July 11, 2005 – The BioSciences Group of Fujitsu Computer Systems today unveiled a new technique for generating enhanced predictions for ADME/Tox research, consisting of a unique docking-based approach combined with off-the-shelf and purpose-built technologies, to develop viable and effective predictive models. The new approach was developed with a commercial collaborator focusing on drug-resistant infectious diseases and cancer.

May 18, 2005  Bio-IT World Expo - Boston, Massachusetts

The BioSciences Group of Fujitsu Offers 'High Throughput Docking' to Overcome Challenges of High Throughput Screening

Bio-IT World Expo - Boston, Massachusetts, May 18, 2005 – At Bio-IT World Expo in Boston, The BioSciences Group of Fujitsu Computer Systems demonstrated its offerings in "High Throughput Docking," (HT Docking) as a means to make High Throughput Screening (HTS) more productive and effective in drug discovery.

April 14, 2005  Sunnyvale, CA

Fujitsu Transfers BioSciences Group to Provide Enhanced Service and Support to Life Sciences Market

Sunnyvale, CA, April 14, 2005 – "We are very pleased to have The BioSciences Group join Fujitsu Computer Systems," said Toshio Morohoshi, President & CEO, Fujitsu Computer Systems Corporation. "We see this transfer as the ideal integration of expertise and services. The BioSciences Group gains expertise in enterprise-scale solutions, and provides life sciences-specific technologies and services in order to introduce Fujitsu offerings in the North American life sciences market."

February 22, 2005  Westwood, MA

Fujitsu America BioSciences Group Announces Agreement with NeurAxon for BioMedCAChe™ Automated Docking Software with ActiveSite™ Module

Westwood, MA, February 22, 2005 – The BioSciences Group of Fujitsu America, Inc., a worldwide leader in providing innovative and reliable solutions to experimental scientists, today announced a licensing agreement for its BioMedCAChe suite of automated docking and molecular modeling software with NeurAxon, Inc., a Canadian company specializing in drug development for pain and central nervous system (CNS) disorders. The deal includes provision of the BioSciences Group’s ActiveSite module for designing effective small molecule inhibitors of protein targets.

January 11, 2005  Westwood, MA

Fujitsu America BioSciences Group Announces Global Licensing Deal with GPC Biotech AG for BioMedCAChe™ Automated Docking Software

Westwood, MA, January 11, 2005 – The BioSciences Group of Fujitsu America, Inc., a worldwide leader in providing innovative and reliable solutions to experimental scientists, today announced a global licensing agreement with GPC Biotech AG, a global cancer drug discovery and development company, for Fujitsu's BioMedCAChe suite of automated docking and molecular modeling software. GPC Biotech will implement BioMedCAChe in its Waltham, Massachusetts and Martinsried/Munich, Germany sites.

August 24, 2004  Philadelphia, PA

Fujitsu America’s BioIT Group Announces New Name, Now Known as BioSciences Group

Philadelphia, PA, August 24, 2004 – At the American Chemical Society National Meeting in Philadelphia, the BioIT Group, a division of Fujitsu America, Inc., which is a wholly-owned subsidiary of global IT giant Fujitsu Limited (TSE:6702), announced that starting today, it would be known as the BioSciences Group.

May 4, 2004  Westwood, MA

Fujitsu’s BioIT Group Releases New Software Application “ActiveSite™” for Designing Effective Small Molecule Inhibitors of Protein Targets

Westwood, MA, May 4, 2004 – The BioIT Group of Fujitsu America, Inc. announced today the release of their new ActiveSite™ software add-on to their BioCAChe™, BioMedCAChe™, and WorkSystem Pro™ products. BioMedCAChe is the CAChe Group’s flagship protein to drug discovery modeling software for the Windows® operating system.